CS Paper Radar

Enhanced MRI brain tumor detection using deep learning in conjunction with explainable AI SHAP based diverse and multi feature analysis

Asif Rahman, Maqsood Hayat, Nadeem Iqbal, Fawaz Khaled Alarfaj, Salem Alkhalaf, Fahad Alturise

cs.CV cs.LG ·submitted 2026-11-05 11:20 UTC · v1
publishedbenchmarkcode/datahighly cited

Abstract

Recent innovations in medical imaging have markedly improved brain tumor identification, surpassing conventional diagnostic approaches that suffer from low resolution, radiation exposure, and limited contrast. Magnetic Resonance Imaging (MRI) is pivotal in precise and accurate tumor characterization owing to its high-resolution, non-invasive nature. This study investigates the synergy among multiple feature representation schemes such as local Binary Patterns (LBP), Gabor filters, Discrete Wavelet Transform, Fast Fourier Transform, Convolutional Neural Networks (CNN), and Gray-Level Run Length Matrix alongside five learning algorithms namely: k-nearest Neighbor, Random Forest, Support Vector Classifier (SVC), and probabilistic neural network (PNN), and CNN. Empirical findings indicate that LBP in conjunction with SVC and CNN obtained high specificity and accuracy, rendering it a promising method for MRI-based tumor diagnosis. Further to investigate the contribution of LBP, Statistical analysis chi-square and p-value tests are used to confirm the significant impact of LBP feature space for identification of brain Tumor. In addition, The SHAP analysis was used to identify the most important features in classification. In a small dataset, CNN obtained 97.8% accuracy while SVC yielded 98.06% accuracy. In subsequent analysis, a large benchmark dataset is also utilized to evaluate the performance of learning algorithms in order to investigate the generalization power of the proposed model. CNN achieves the highest accuracy of 98.9%, followed by SVC at 96.7%. These results highlight CNN's effectiveness in automated, high-precision tumor diagnosis. Code: https://github.com/asifrahman557/BrainTumorDetection

Comment
15 pages. Published in Scientific Reports 15, 29411 (2025). Open access under CC BY 4.0
Journal ref
Scientific Reports 15, 29411 (2025)
DOI
10.1038/s41598-025-14901-4

Closest papers

Nearest neighbours by meaning across the whole index.

ORB-SVM : An Innovative Hybrid Framework for Efficient Brain Tumor Detection from MRI Scans

cs.CV cs.AI ·2026-09-02 ·Amirhosein Azarpour
top venue similarity 0.71
Abstract · 6 pages , 7 figures

Brain cancer remains one of the most significant challenges in modern medicine, where the accuracy of early stage diagnosis is a decisive factor in patient survival and treatment efficacy. Although Magnetic Resonance Imaging (MRI) is the established gold standard for visualizing neurological structures, the interpretation of these high dimensional scans is often complicated by subjective variability among practitioners and the inherent noise present in complex medical images. While contemporary approaches frequently rely on high parameter deep learning architectures, such models often involve significant computational costs and require extensive data for effective training. This study introduces a hybrid framework that utilizes the Oriented FAST and Rotated BRIEF (ORB) algorithm for precise feature extraction and a Support Vector Machine (SVM) for classification [1], [2]. The proposed approach achieves a sub- stantial data reduction of approximately 99.5%, which effectively minimizes the influence of non informative background data while preserving critical diagnostic patterns essential for tumor identification. By balancing feature sparsity with a robust kernel based classifier, this methodology addresses the limitations of over parameterized systems while maintaining high diagnostic integrity. Experimental evaluations conducted on the Br35H dataset demonstrate that the framework attains a classification accuracy of 97.5%. The findings suggest that the integration of localized feature representation and optimized classification provides a reliable and resource efficient alternative for medical image analysis, offering a structured solution that maintains per- formance without the need for extensive computational overhead.

0.50

BrainAid: Efficient Brain Tumor Detection Using Lightweight CNNs and Explainable AI for Resource-Constrained Environments

cs.CV ·2026-10-10 ·Sai Sriram Gonthina, Ross Gore, Bikash Chandra Singh, Pronaya Bhattacharya, Sachin Shetty +2 more
similarity 0.68
Abstract

A brain tumor is an unusual growth of cells in the brain that can be cancerous or not, affecting normal brain function and causing serious risk to health. Existing solutions for brain tumor classification, such as expert manual evaluations of magnetic resonance imaging (MRI) scans, are generally inconsistent as different professionals have different criteria and can be resource-intensive, leading to delayed diagnoses. Additionally, while deep learning models have demonstrated potential, they typically require significant computational resources, motivating the need for more efficient and accessible diagnostic tools that can be deployed in real-time healthcare settings. To address these limitations, this study presents BrainAid, which makes efficient use of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) for effective classification of four-class classification of glioma, meningioma, pituitary tumor, and no-tumor MRI scans, outperforming all the standard models such as VGG16, Inception-V3, ResNet-50 and so, while integrating Explainable AI (XAI) to improve interpretability. The BrainAid is trained to classify tumors with a high precision of 98%, achieving an F1 score of 98% and an accuracy of 98% using publicly available dataset. The model is deployed on a Raspberry Pi, demonstrating efficiency in low-resource environments. This system shows the feasibility of real-time, edge-based tumor classification, providing quick diagnostic support for medical professionals and enhancing patient care in resource-limited healthcare facilities and underserved areas.

0.07

A Trustworthy Clinical Decision Support Framework for Brain Tumor MRI Classification: Integrating Attention-Guided Learning, Explainable AI, and Out-of-Distribution Validation

cs.CV cs.AIcs.LG ·2026-10-06 ·Arjun Kumar Gupta, Harminder Pal Monga
publishedbenchmark similarity 0.67
Abstract · Accepted for presentation at the IC3AI-2026 IEEE conference in Dec 2026. It has been accepted/selected but is not yet published. 6 pages, 4 …

Deep learning models for brain tumor diagnosis need to do more than achieve high classification accuracy. For practical use, they should also provide understandable predictions, recognize unsuitable inputs, and work within a usable clinical system. This paper presents a framework for classifying brain MRI into four categories: glioma, meningioma, pituitary tumor, and no tumor. The model uses InceptionResNetV2 with a Convolutional Block Attention Module (CBAM), while Grad-CAM provides visual explanations of its predictions. A two-stage out-of-distribution (OOD) mechanism screens unsuitable inputs using an initial grayscale check followed by Mahalanobis distance, softmax confidence, and predictive entropy. These components are brought together in NeuroScan AI, a real-time web application. Evaluated on a Mendeley brain tumor MRI dataset of 12,064 images, the framework achieved 98.70% validation accuracy, 96.73% test accuracy, and a macro-average AUC of 0.9965. The OOD pipeline achieved 99% detection accuracy on a preliminary 100-image benchmark. Grad-CAM visualizations showed qualitative correspondence with clinically established tumor locations across all four classes. Overall, the work brings classification, explainability, input validation, and deployment into one framework, while recognizing that broader clinical and OOD validation is still required.

0.25

GaborFlow: Hardware-Software Co-Optimization of Gabor Filter Accelerator Design

cs.AR ·2026-10-10 ·Priyanka Agarwal, Pruthvi Parate, Raghav Khurana, Madhav Rao
similarity 0.64
Abstract · 8 pages, 3 figures, 6 tables

Brain tumor classification from MRI scans represents a critical challenge in medical imaging, where accuracy directly impacts patient outcomes. This paper introduces GaborFlow, a novel hardware-software co-optimization framework that revolutionizes the design of the Gabor Filter accelerator for generating feature maps to enhance brain tumor detection. Unlike conventional approaches that rely on fixed filter parameters, our method employs trainable Gabor coefficients within a carefully optimized range, integrated with an EfficientNet-B0 backbone CNN architecture. The innovation lies in the synergistic combination of software optimization through Bayesian hyperparameter tuning and hardware efficiency through precision-optimized multipliers. Our GF baseline accelerator achieves remarkable results, with 98.6% classification accuracy, 28.08% power benefits, and 48.83% footprint savings compared to state-of-the-art implementations, demonstrating that medical AI can be both highly accurate and energy-efficient. The hardware design files are made freely available for easy adoption and further usage by the researchers and designers.

0.32

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

cs.CV ·2026-11-09 ·Akwasi Asare
similarity 0.64
Abstract · Under review at Scientific Report Journal, Springer

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

0.15

Explainable and CPU-Efficient Brain Tumor Classification from MRI Using Two-Phase EfficientNetB3 Fine-Tuning

cs.CV ·2026-11-18 ·Deepro Das, Saad Kabir Uddin, Mohammad Alauddin, Bornali Sarker, Thasnim Akhter
similarity 0.63
Abstract · 6 pages, 5 figures, 6 tables

Brain tumors are among the most lethal neurological disorders, with over 308,000 new diagnoses annually worldwide. Accurate classification of tumor type from Magnetic Resonance Imaging (MRI) scans is critical for treatment planning; however, manual radiological interpretation is time-consuming and prone to inter-observer variability. This paper proposes an automated deep learning pipeline for four-class brain MRI classification (glioma, meningioma, no tumor, and pituitary tumor) using EfficientNetB3 transfer learning with a custom classification head. A two-phase training strategy is adopted: Phase 1 trains the head with a frozen backbone (best validation accuracy: 92.77%), and Phase 2 selectively fine-tunes the top 37 layers at a 100x reduced learning rate (best validation accuracy: 94.91%). On an independent balanced test set of 1,600 MRI images, the system achieves 90.62% overall accuracy and a macro-average AUC of 0.9854. Gradient-weighted Class Activation Mapping (Grad-CAM) is integrated for class-discriminative visual explainability. The proposed system simultaneously addresses three dimensions absent in prior work: high accuracy, CPU-only computational efficiency, and clinical interpretability.

0.14

A Tumour-Aware Multimodal Framework for Explainable Prediction of IDH Mutation in Gliomas from Multi-Sequence MRI

eess.IV cs.CV ·2026-11-13 ·Tahsien Al-Quraishi, Waseem Alwan Zaboon, O. S. Albahri, Raza Nowrozy
similarity 0.63
Abstract · 45 pages, 12 figures, 4 tables. Preprint of an article submitted for consideration in International Journal of Information Technology & Deci…

Accurate prediction of isocitrate dehydrogenase (IDH) mutation status is essential for glioma diagnosis, prognosis, and treatment planning. Although recent deep learning approaches have demonstrated promising performance, many rely on whole-brain feature extraction and provide limited interpretability. This study proposes a tumour-aware multimodal framework for explainable, non-invasive prediction of IDH mutation status from multiparametric magnetic resonance imaging (MRI). The proposed framework integrates four MRI sequences (T1, T1CE, T2, and FLAIR), tumour subregion segmentation, quantitative radiomic descriptors, and clinical information within a unified deep learning architecture. An ablation study was conducted to evaluate the contribution of tumour-aware learning, radiomic features, and clinical variables. Model performance was assessed using multiple complementary evaluation metrics, including accuracy, precision, recall, F1-score, balanced accuracy, receiver operating characteristic analysis, confusion matrix evaluation, and Grad-CAM visualisation. Experimental results demonstrated that the proposed multimodal framework consistently outperformed the baseline MRI-only model, with the Clinical Fusion model achieving the strongest overall predictive performance. The integration of tumour-aware learning, radiomic descriptors, and clinical information progressively improved classification performance, while Grad-CAM visualisations indicated that the model predominantly focused on biologically relevant tumour regions. These findings suggest that tumour-aware multimodal feature integration enables accurate, interpretable, and non-invasive molecular profiling of gliomas and provides a promising foundation for future clinical decision support in precision neuro-oncology.

0.12

A new MRI-based feature for quantifying the Diffuse Low-Grade Glioma brain infiltration and discriminating patterns of patients

eess.SP stat.AP ·2026-10-05 ·Jean-Marie Moureaux, Sophie Wantz-M{é}zi{è}res, Cyril Brzenczek, Marie Blonski, Luc Taillandier
published similarity 0.62
Abstract

Gliomas are the most common type of primary brain tumors. Diffuse low-grade gliomas (DLGGs) are slow-growing tumors that are often minimally symptomatic for a long period of time. They progress to a higher grade, resulting in the patient's death. Treatments include surgery, chemotherapy and radiation therapy to control tumor progression. Responses to treatments are highly variable among patients. Furthermore, the diffuse component of this tumor entity has been observed but is not yet well measured. Here, we propose a new variable to quantify glioma morphology, called ESVR (Extra Sphere Volume Ratio). We use then a machine learning approach to study the importance of different variables for discriminating patterns of patients: patient-specific variables, genetic alterations of tumor tissue, and some image-based variables like ESVR and the volume of the tumor, obtained by MRI analysis. Our machine learning approach shows that the patient's age and ESVR at diagnosis, as well as the pathology results seem to play an important role. Taking the highlighted variables into account could thus help to model the tumor behavior. In association with other classical biomarkers, our new ESVR feature could help the clinician to manage the treatment, as it carries significant information in terms of aggressivity of the DLGG.

0.48